Get the Stockscreener App
138.56
1.16%
-1.635
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $138.56, with a volume of 213.69K.
It is down -1.16% in the last 24 hours and up +4.38% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$140.20
Open:
$139.3
24h Volume:
213.69K
Relative Volume:
0.28
Market Cap:
$7.44B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-15.03
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-2.89%
1M Performance:
+4.38%
6M Performance:
-15.82%
1Y Performance:
-18.74%
1-Day Range:
$137.44
$139.62
1-Week Range:
$137.44
$148.75
52-Week Range:
$125.94
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
138.59 | 7.53B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
107.33 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.32 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.75 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.36 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.73 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Strs Ohio Reduces Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo wants Apple’s bid to erase a $634 million patent-infringement verdict overturned - MacTech.com
Masimo Fights Apple Bid to Undo $634 Million Apple Watch Verdict - Bloomberg Law News
Masimo to Sell Consumer Audio Business to HARMAN for $350 Million - rAVe [PUBS]
Massachusetts Financial Services Co. MA Boosts Holdings in Masimo Corporation $MASI - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Masimo Corporation $MASI - MarketBeat
Medical Device Connectivity Market is expected to generate a revenue of USD 13.4 Billion by 2032, Globally, at 23.40% CAGR: Verified Market Research® - GlobeNewswire Inc.
Masimo Releases Preliminary Q4 Results - ocbj.com
Masimo (NASDAQ:MASI) Updates Q4 2025 Earnings Guidance - MarketBeat
Owlet Stock Up More Than 82% in the Past 6 Months: Still Worth Buying? - Finviz
Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Why Masimo Corporation (3M4) stock is a strong analyst pickPrice Action & AI Based Buy and Sell Signals - ulpravda.ru
Why Masimo Corporation stock is trending among retail tradersDay Trade & Daily Stock Trend Reports - Улправда
How rising interest rates impact Masimo Corporation stockQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - ulpravda.ru
Masimo’s Pediatric SpO2 Study With Philips Monitors: What Investors Should Watch - TipRanks
How to watch Masimo’s talk at the J.P. Morgan 2026 healthcare event - Stock Titan
Here's Why You Should Retain Masimo Stock in Your Portfolio Now - The Globe and Mail
Masimo (NASDAQ:MASI) Reaches New 12-Month LowHere's What Happened - MarketBeat
Masimo Corporation (MASI) Stock Analysis: Exploring a 44% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Weekend Round-Up: TSMC's US Export Approval, Masimo's Quality Concerns And Apple's Vision Pro Woes - Benzinga
MASI (Masimo) Net Interest Income : $-34 Mil (TTM As of Sep. 2025) - GuruFocus
Apple's Vision Pro Production Plans, Masimo's Quality Score Declines Despite Patent Win, And More: This Week In Appleverse - Benzinga
MASI (Masimo) Total Equity : $810 Mil (As of Sep. 2025) - GuruFocus
MASI Stock Price, Forecast & Analysis | MASIMO CORP (NASDAQ:MASI) - Chartmill
Apple's Rival Masimo Tumbles In Quality Despite $634 Million Patent Win Over iPhone-Maker - Benzinga
Masimo Corporation $MASI Shares Sold by Voya Investment Management LLC - MarketBeat
Wells Fargo Maintains Overweight on Masimo (MASI) Following Investor Day Confidence In Long-Range Revenue Targets - Finviz
Masimo Corporation stock hits 52-week low at 131.47 USD By Investing.com - Investing.com South Africa
Masimo Corporation stock hits 52-week low at 131.47 USD - Investing.com
Masimo Corporation $MASI Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Masimo’s Turnaround Hinges On Healthcare Growth And A Consumer Breakup - Finimize
Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech - Kalkine Media
Apple Seeks To Overturn $634M Masimo Patent Verdict - Law360
Apple Asks Judge to Toss Masimo’s $634 Million Watch-Alerts Win - Bloomberg Law News
Masimo Corporation $MASI Shares Sold by Perpetual Ltd - MarketBeat
Masimo Corporation $MASI Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Corient Private Wealth LLC Sells 17,624 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Masimo stock hits 52-week low at 133.66 USD By Investing.com - Investing.com Nigeria
Masimo stock hits 52-week low at 133.66 USD - Investing.com
Masimo Corporation $MASI Shares Sold by Holocene Advisors LP - MarketBeat
Masimo Corporation $MASI Shares Sold by Liontrust Investment Partners LLP - MarketBeat
Masimo Corporation $MASI Shares Purchased by Bellevue Group AG - MarketBeat
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):